Drug intelligence / Profile preview

18F-MGX-110S

Development stage
Preclinical
Lead developer
Stanford University
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

18F-MGX-110S (also referred to as [18F]MGX-110S) is a fluorine-18-labeled positron emission tomography (PET) radiotracer targeting G-protein coupled receptor 84 (GPR84). GPR84 is a pro-inflammatory receptor predominantly expressed on myeloid cells, such as microglia and macrophages, and is highly upregulated during innate immune activation. Developed by researchers at Stanford University in collaboration with the University of Milan, University of Glasgow, and University of Michigan, 18F-MGX-110S is designed to cross the blood-brain barrier and detect neuroinflammation and systemic inflammation. In preclinical models of Alzheimer's disease (5xFAD mice) and multiple sclerosis (EAE mice), 18F-MGX-110S demonstrated high specificity and superior sensitivity for early-stage neuroinflammation compared to traditional translocator protein 18 kDa (TSPO) PET tracers.

Other names
[18F]MGX-110S
02

Targets

GPR84

Beyond the preview

Go deeper on 18F-MGX-110S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-MGX-110S.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call